News
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Aaeon has turned to Genio processors from fellow Taiwanese company Mediatek for its latest Smark modules. The first Aaeon products to get MediaTek ICs, uCOM-M700 has an octa-core Genio 700, while uCOM ...
“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...
Casa Stagnitta Palermo is the best place for coffee and granita in the capital of Sicily. Located in the lovely Bellini ...
The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...
After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...
The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.
DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.
Nyxoah SA may now help make dreams come true here in the U.S. with its FDA approval for the Genio system for the treatment of ...
4d
InvestorsHub on MSNNyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment
Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...
Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ: NYXH) stock jumped 9.4% following FDA approval of its Genio system for treating moderate to severe obstructive sleep apnea (OSA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results